Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.6K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K
Gene Therapy00:59

Gene Therapy

28.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hearing, Voice and Speech Disorders in 10-Year-Old-Boy with Facio-Scapulo-Humeral Dystrophy (FSHD) - Case Study.

The application of clinical genetics·2026
Same author

Enhancing antimicrobial stewardship and health literacy in Europe - moving forward through education and empowerment.

Public health in practice (Oxford, England)·2026
Same author

Physiotherapy in Text Neck Syndrome: A Scoping Review of Current Evidence and Future Directions.

Journal of clinical medicine·2025
Same author

Health behaviors and problems in Polish homeless men.

Frontiers in public health·2023
Same author

Anxiety and Health Concerns among Healthcare Personnel Working with COVID-19 Patients: A Self-Assessment Study.

Medical science monitor : international medical journal of experimental and clinical research·2023
Same author

The Functioning of Hospice in the Perception of Family Members of Cancer Surgery and Hospice Patients.

International journal of environmental research and public health·2023

Related Experiment Video

Updated: Apr 7, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.5K

Duchenne muscular dystrophy: current cell therapies.

Dorota Sienkiewicz1, Wojciech Kulak2, Bożena Okurowska-Zawada1

  • 1Department of Pediatric Rehabilitation Medical University, Bialystok, Poland.

Therapeutic Advances in Neurological Disorders
|July 3, 2015
PubMed
Summary

This review examines Duchenne muscular dystrophy treatments, focusing on stem cell therapy and granulocyte colony-stimulating factor (G-CSF). Research highlights progress in pediatric muscle disorder therapies.

Keywords:
Duchenne muscular dystrophyG-CSFstem cells

More Related Videos

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.9K
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

7.3K

Related Experiment Videos

Last Updated: Apr 7, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.5K
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.9K
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

7.3K

Area of Science:

  • Genetics and Molecular Biology
  • Neurology
  • Pediatrics

Background:

  • Duchenne muscular dystrophy (DMD) is a severe, inherited pediatric neuromuscular disorder.
  • X-linked inheritance pattern affects males primarily, causing progressive muscle degeneration.
  • Decades of research aim to identify effective therapeutic strategies for DMD.

Purpose of the Study:

  • To review current therapeutic methods for Duchenne muscular dystrophy.
  • To analyze scientific literature primarily from 2000-2014.
  • To focus on stem cell therapy and G-CSF in DMD treatment.

Main Methods:

  • Systematic review of scientific articles.
  • Literature search conducted using the PubMed database.
  • Analysis focused on studies published between 2000 and 2014.

Main Results:

  • Identified key therapeutic approaches for Duchenne muscular dystrophy.
  • Evaluated the potential of stem cell therapy in DMD.
  • Assessed the role of granulocyte colony-stimulating factor (G-CSF) in managing DMD.

Conclusions:

  • Current Duchenne muscular dystrophy therapies are evolving.
  • Stem cell therapy and G-CSF show promise but require further investigation.
  • Continued research is crucial for developing effective DMD treatments.